KOSDAQFinance309960

LB Investment

₩4,320▲ 0.70%2026-10-02 close
Market Cap
₩100.3B
Turnover
₩100M
Volume
30,000 shares
Shares out.
23.2M
PER
7.0×
PBR
0.8×
EPS
₩606
Dividend Yield
4.72%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q3–2026Q2) · Dividend yield is based on ₩200 per share · Prices as of the 2026-10-02 close

01

Report overview

A Venture Capital House Riding the IPO Exit Wave

A wave of portfolio company listings drove a sharp jump in equity-method gains and performance fees, lifting 2025 net profit well above the prior year, while a pipeline of large IPO candidates including Musinsa remains the key swing factor for 2026 earnings.

  1. 1

    2025 consolidated revenue reached KRW 26.4 billion with operating profit of KRW 9.7 billion and owners' net profit of KRW 12.4 billion, an operating margin of 36.6%

  2. 2

    Quarterly results swing widely depending on the timing of portfolio IPOs and exits, with net profit concentrated in the third and fourth quarters of 2025

  3. 3

    For 2026 the company has set a target of growing all three pillars—fundraising, investment, and exits—by more than 30% year on year

  4. 4

    A new fund of roughly KRW 300 billion pushed assets under management past KRW 1.5 trillion, while a third secondary fund is currently being raised

  5. 5

    The portfolio includes large IPO candidates such as Musinsa, Recence Medical, and Rableup, making 2026 exit performance a key point of focus

02

Business structure

LB Investment, launched in 1996 as LG Venture Capital and renamed to its current identity in 2008, is one of Korea's leading venture capital firms whose core business is forming and operating venture investment associations and private equity funds (PEFs) to invest in early- and growth-stage companies and to exit through IPOs or M&A.

The firm operates twelve venture investment associations and one private equity partnership, with operating revenue composed of management fees, performance fees, gains on financial instruments, and equity-method gains.

Its investment focus centers on artificial intelligence and deep tech, extended into bio/healthcare, content and services, and robotics, with recent expansion into next-generation sectors such as aerospace.

The firm has invested in more than 550 startups cumulatively, listed 140 of them, and grown 14 into unicorns valued above KRW 1 trillion, earning it a reputation as a 'unicorn factory.' Notable portfolio names include past successes such as HYBE, Pearl Abyss, and Kakao Games, alongside current holdings like Musinsa, Ably, Nota, Protina, RevsMed, and Semifive.

Its controlling shareholder is holding company LB Co., which owns 100% of shares, while listed peers include Ajoo IB Investment, SBI Investment, SV Investment, Mirae Asset Venture Investment, and Daol Investment.

Recently the firm has continued raising hybrid combined funds that blend secondary and M&A strategies, backed by institutional limited partners such as the Korea Development Bank, the Korea Teachers Pension, and church pension funds.

The firm positions its 'full-cycle investing' approach of repeated follow-on investment plus 'selection and concentration' on a smaller number of portfolio companies as its core competitive edge.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q2₩6.9B₩2.6B38.4%
2025Q3₩8.1B₩5.3B64.9%
2025Q4₩6.1B₩700M11.8%
2026Q1₩13.1B₩2.1B16.1%
2026Q2₩8.5B₩3.4B40.2%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩18.5B₩4.8B₩3.9B25.7%4.1%9.3%
2023₩27.6B₩8.5B₩6.4B30.7%5.6%10.0%
2024₩30.3B₩10.9B₩8.6B35.9%7.2%8.9%
2025₩26.4B₩9.7B₩12.4B36.6%9.8%6.9%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-09-05

04

Earnings analysis

Consolidated revenue for 2025 came to KRW 26.4 billion, down from KRW 30.3 billion in 2024, yet operating profit reached KRW 9.7 billion and owners' net profit KRW 12.4 billion—a sharp increase from KRW 8.6 billion in 2024—so revenue and profit moved in opposite directions.

The operating margin improved steadily from 25.7% in 2022 to 30.7% in 2023, 35.9% in 2024, and 36.6% in 2025.

On a quarterly basis, revenue of KRW 6.88 billion, operating profit of KRW 2.64 billion, and net profit of KRW 2.13 billion in the second quarter of 2025 jumped to revenue of KRW 8.14 billion, operating profit of KRW 5.28 billion, and net profit of KRW 4.65 billion in the third quarter, a swing attributed to equity-method valuation gains on portfolio companies and a concentration of asset exits.

In the fourth quarter, revenue fell to KRW 6.09 billion and operating profit dropped sharply to KRW 0.72 billion, yet net profit rose further to KRW 4.86 billion, suggesting non-operating items or the timing of performance-fee recognition played a large role.

In the first quarter of 2026, revenue surged to KRW 13.1 billion, well above prior quarters, but net profit was only KRW 1.27 billion, showing revenue growth did not translate directly into profit growth, before the second quarter returned to steadier profitability with revenue of KRW 8.54 billion, operating profit of KRW 3.44 billion, and net profit of KRW 3.15 billion.

Over the trailing four quarters (Q3 2025 through Q2 2026), cumulative owners' net profit reached KRW 13.9 billion, already exceeding the full-year 2025 net profit of KRW 12.4 billion.

On a cash-flow basis, operating cash flow was negative at KRW -6.3 billion in 2022 and KRW -2.6 billion in 2024, before turning positive at KRW 1.6 billion in 2023 and KRW 5.6 billion in 2025, an improving trend.

Equity capital rose steadily from KRW 94.5 billion in 2022 to KRW 127.0 billion in 2025 across four consecutive years, while the debt ratio fell from 10.0% in 2023 to 6.9% in 2025, reflecting a stable and strengthening capital structure.

05

Industry analysis

Korea's venture capital industry is seen as entering a recovery phase in 2026 after roughly two years of capital scarcity, though the recovery is uneven across segments.

Heungkuk Securities' research center projected in a February 2026 interview that 2026 would see 86 new listings in total—12 on KOSPI and 74 on KOSDAQ—approaching 2021 levels and marking the start of an upward IPO cycle.

At the same time, some analysis points to a widening 'barbell' style polarization, with capital concentrating on core sectors such as AI, bio, and semiconductors and on companies with proven technology and track records, while early-stage and non-mainstream areas see slower investment.

Additional supply of policy capital such as the National Growth Fund and refinements to venture capital operating regulations are cited as factors improving the fund-raising environment, alongside growing emphasis on distributed-to-paid-in (DPI) cash-return metrics as a performance benchmark.

Secondary markets are emerging as a mainstream exit channel, a trend LB Investment is addressing by raising its third secondary fund backed by capital from the Korea Development Bank, the Korea Teachers Pension, and a church pension fund.

Within the industry, deal-sourcing systems, value-adding capability, and the ability to execute exit strategies beyond IPOs alone are seen as the key variables widening performance gaps between houses, and LB Investment points to its unicorn track record and full-cycle investment strategy as its competitive edge.

06

Outlook

LB Investment has set a 2026 target of growing all three pillars—fundraising, investment, and exits—by more than 30% year on year, with specific goals of roughly KRW 400 billion in fundraising and about KRW 200 billion in new investment execution.

On the exit side, the firm aims to raise its portfolio IPO count into double digits in 2026, up from eight in 2025, and has stated it holds a number of IPO-track portfolio companies including Musinsa, Recence Medical, and Rableup.

A company representative said the firm expects more than KRW 200 billion in exit proceeds from its IPO-track portfolio alone, describing Musinsa as a company that represents Korea's fashion platform market and expects it to draw strong attention in the domestic IPO market.

On the investment strategy front, the firm is expanding AI-centered deep-tech investment, with a company representative stating it plans roughly KRW 200 billion in new investment this year, continuing to focus on AI infrastructure, deep tech, and next-generation industry sectors.

On fund formation, after the roughly KRW 300 billion 'LB Next Future Fund' pushed assets under management past KRW 1.5 trillion, the firm is now raising a third secondary fund of more than KRW 200 billion backed by capital from the Korea Development Bank, the Korea Teachers Pension, and a church pension fund.

In an interview with The Bell, the CEO said assets under management are expected to expand to around KRW 1.5 trillion in scale, describing the year as one the firm is preparing to elevate beyond Korea's top VC status toward a global level, while also outlining plans to expand overseas investment and cooperative networks with top-tier global VCs.

07

Valuation

PER
7.0×
PBR
0.8×
ROE
11.4%
EPS
₩606
BPS
₩5,507
Dividend per share
₩200

At the time of listing, the average price-to-book ratio of comparable firms selected by the lead underwriter—including Ajoo IB Investment, SBI Investment, SV Investment, and Mirae Asset Venture Investment—stood at around 1.21 times, which can serve as a reference point for the kind of premium to net assets at which the venture capital sector has typically traded.

Since listing, however, industry media have pointed out that the absence of a clear shareholder-return policy or value-up strategy has weighed on the share price despite steady top-line growth and improving results.

Net profit has moved from a period of concern about losses to a steadily expanding, recovering trend since 2022, and equity capital has also grown for four consecutive years, indicating improving financial fundamentals.

On dividends, the disclosed per-share cash dividend level appears relatively modest compared with other listed venture capital peers, which relates to the firm's capital-allocation approach of prioritizing new fund formation and follow-on investment over cash distribution.

Because results swing significantly by quarter depending on the timing of equity-method valuation gains and performance-fee recognition, this volatility should be kept in mind when interpreting any valuation metric at a given point in time.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-09-05

08

Bull factors

Entering a Portfolio IPO Exit Cycle

In 2025, four portfolio companies—Nota, Protina, RevsMed, and Semifive—crossed the KRW 1 trillion valuation mark after listing, lifting both equity-method valuation gains and exit proceeds simultaneously.

Heading into 2026 the firm still holds several large IPO candidates including Musinsa, Recence Medical, and Rableup, leaving room for a similar earnings pattern to repeat. The company itself has stated it expects more than KRW 200 billion in exit proceeds from its IPO-track portfolio alone.

Growing AUM and a Diversified Fund Structure

A new fund of roughly KRW 300 billion pushed assets under management past KRW 1.5 trillion, and the fund lineup is expanding to include hybrid vehicles that combine secondary and M&A strategies.

The firm has been steadily attracting policy and institutional capital from the Korea Development Bank, the Korea Teachers Pension, and a church pension fund, with potential to broaden the management-fee base over time. Diversifying fund types is also expected to reduce dependence on any single exit channel.

Early Positioning in AI and Deep Tech

The company has named AI-centered deep-tech investment expansion as a core 2026 strategy, with plans for roughly KRW 200 billion in new investment.

Industry analysis also anticipates a polarizing structure in which capital concentrates on core sectors such as AI, bio, and semiconductors, suggesting houses with an established track record could find themselves relatively favorably positioned.

The firm's full-cycle investment strategy of carrying early-stage stakes through to follow-on rounds ties directly into this approach.

09

Bear factors

High Earnings Volatility

Quarterly results are heavily driven by the timing of equity-method valuation gains and performance-fee recognition, making them difficult to predict.

In the first quarter of 2026, revenue jumped to KRW 13.1 billion yet net profit was only about KRW 1.3 billion, illustrating a structural pattern in which revenue growth does not automatically translate into profit growth. This volatility makes it difficult to judge business direction from any single quarter's results.

Lack of a Clear Shareholder-Return Policy

Industry media have pointed out that despite steady top-line growth since listing, LB Investment has not presented a clear value-up strategy or shareholder-return policy, which has coincided with diminished market attention.

Dividend levels also appear relatively low compared with other listed venture capital peers, related to the firm's policy of prioritizing capital for new fund commitments. A market that lacks clarity on this capital-allocation priority could weigh on valuation.

Intensifying Competition and Polarization in the VC Industry

Industry experts diagnose that in the 2026 VC market, capital will concentrate on core sectors and later-stage companies while funding for early-stage and non-mainstream areas tightens further, deepening polarization.

This signals a differentiation phase where performance diverges clearly based on firm and individual capability, potentially disadvantaging houses that lack strong deal-sourcing or value-adding capacity relative to peers. LB Investment also carries the ongoing burden of adapting to this shifting competitive environment.

10

Risk factors

Portfolio Valuation Risk

A large portion of results stems from equity-method valuation gains on unlisted portfolio holdings and price movements of listed portfolio companies, so a cooling IPO market or falling share prices among listed holdings could rapidly shrink profit.

The disconnect between revenue and net profit seen between the fourth quarter of 2025 and the first quarter of 2026 underscores this risk. A delay in the listing timeline of any major portfolio company such as Musinsa could also affect exit expectations.

Fundraising and LP Dependency Risk

New fund formation depends heavily on a small number of institutional limited partners such as the Korea Development Bank, the Korea Teachers Pension, and a church pension fund, so changes in these institutions' alternative-investment policies or commitment sizes could affect fundraising target achievement.

As the role of policy capital grows, related institutional or budgetary changes also warrant attention. A delay in the targeted KRW 400 billion fundraising could have knock-on effects on new investment execution plans.

Regulatory and Market Environment Risk

Changes to IPO- and listing-related regulations, such as tightened KOSDAQ delisting criteria and mandatory lock-up commitment rules, can directly affect the timing and manner of portfolio company listings.

As legal and institutional frameworks governing venture capital operations continue to be revised, fund management strategies may need to adjust accordingly.

In addition, because Korea's IPO market tends to lag broader market and rate conditions, shifts in the global rate or equity environment could affect exit timing with a delay.

11

What to watch next

  1. Mid-November 2026

    Check the third-quarter 2026 earnings disclosure to see whether equity-method valuation gains are reflected and whether quarter-to-quarter earnings volatility continues.

  2. During the second half of 2026

    Monitor whether major IPO-candidate portfolio companies such as Musinsa, Recence Medical, and Rableup file for preliminary listing review and finalize their listing schedules.

  3. During the second half of 2026

    Check whether the final size and limited-partner composition of the third secondary fund, backed by capital from the Korea Development Bank, the Korea Teachers Pension, and a church pension fund, are confirmed.

  4. Around January 2027

    Review year-end results to check whether the 2026 annual targets—roughly KRW 400 billion in fundraising, about KRW 200 billion in new investment execution, and double-digit portfolio IPO exits—were achieved.

12

Overall view

LB Investment saw a significant increase in owners' net profit in 2025 on the back of successful listings by numerous portfolio companies, and trailing four-quarter cumulative net profit has already exceeded the full-year figure, signaling that an exit cycle has taken hold.

Still, quarterly results show wide swings driven by the timing of equity-method valuation gains and performance-fee recognition, with revenue and profit repeatedly moving in opposite directions.

Heading into 2026, the firm holds a number of large IPO candidates including Musinsa, making further exit performance a key earnings variable, while assets under management continue to expand through a new roughly KRW 300 billion fund and a third secondary fund now being raised.

At the same time, industry-wide diagnoses point to deepening polarization as capital concentrates on core sectors and later-stage companies, requiring ongoing adaptation to a shifting competitive landscape.

The absence of a clear shareholder-return policy has been a recurring point raised since listing, and market attention to future capital-allocation direction is likely to continue.

On balance, the firm's financial structure and profit-recovery trend are improving, but earnings volatility and uncertainty around the timing of major IPOs remain factors to weigh together.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. fntimes.com
  2. m.thebell.co.kr
  3. ibtomato.com
  4. newstopkorea.com
  5. m.irgo.co.kr
  6. lbinvestment.com
  7. kr.investing.com
  8. tokenpost.kr
  9. thevc.kr
  10. m.finance.daum.net
  11. lbinvest.mycafe24.com
  12. fntimes.com
  13. markets.hankyung.com
  14. comp.fnguide.com
  15. m.thinkpool.com
  16. comp.fnguide.com
  17. comp.fnguide.com
  18. dealsite.co.kr

Report written 2026-09-05 · Data as of 2026-09-04

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.